Product Details

RenuTend suspension for injection for horses

MA holder
Boehringer Ingelheim Vetmedica GmbH
VM number
EU/2/22/282/001
Territory
Northern Ireland
Aligned product
Date of issue
19/04/2022
Authorisation route
Centralised
Active substances
  • Tenogenic primed equine allogeneic peripheral blood-derived mesenchymal stem cells (tpMSCs)
Controlled drug
No
Target species
  • Horses
Distribution category
POM-V
Distributors